In collaboration with Laboratoires Thea, Quantel Medical participates to several dry eye events to promote LacryDiag and LacryStim devices.
0
0
In collaboration with Laboratoires Thea, Quantel Medical participates to several dry eye events to promote LacryDiag and LacryStim devices.
AOUT 2019
Quantel Medical announces the acquisition of the Slovenian company Optotek Medical d.o.o., specialised in the development of optical solutions and lasers for medical applications.
This acquisition is the outcome of a long collaboration between the two companies through the development and supply of devices as OEM for its anterior chamber lasers range.
&
&
Quantel Medical announces the acquisition of the Slovenian company Optotek Medical d.o.o., specialised in the development of optical solutions and lasers for medical applications.
This acquisition is the outcome of a long collaboration between the two companies through the development and supply of devices as OEM for its anterior chamber lasers range.
LASER
LASER
DRY EYE
DRY EYE
ULTRASOUND
ULTRASOUND
ACQUISITION OF THE COMPANY OPTOTEK MEDICAL
ACQUISITION OF THE COMPANY OPTOTEK MEDICAL
CORPORATE
CORPORATE
MARCH 2019
ABSolu receives approval from the US Food & Drug administration (FDA).
SEPTEMBER 2019
Introduction of the next generation PDT laser, Vitra 689.
Sales availability: January 2020
MARCH 2019
LacryDiag & LacryStim are presented during several dry eye events in collaboration with Laboratoires Théa.
MAY 2019
Two new probes for Evotouch & Evotouch +!
A phased array pobe and an endocavitary probe developped
OCTOBER 2019
New optional camera video imaging system for Easyret laser.
Sales availability: January 2020
MAY 2019
The dry eye range is launched in Latin America during a Quantel Medical symposium with Mario de la Torre, Guillermo Tapia Herrera and Alejandro Navas.
SEPTEMBER 2019
As a result of Quantel Medical & Thea collaboration, a new book on ophthalmic ultrasound using ABSolu & Aviso platform is published.
DECEMBER 2019
Vitra 2 receives approval from the US Food and Drug Administration (FDA).
MAI 2019
LacryStim is presented for the first time to the European ophthalmologists during the SFO congress in Paris.
